Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Cancer - DOR BioPharma Announces NIH Grant Award to Support Phase 1/2 Clinical Trial of DOR201 in Radiation Enteritis
Breast Cancer - New findings from M. Martin and co-researchers in the area of breast cancer described
Breast Cancer - Research in the area of breast cancer reported from University of Athens
Breast Cancer - Studies from P. Fumoleau and colleagues provide new data on breast cancer
Diabetes - Research data from University of Lille update understanding of diabetes
Drug Delivery - New findings from Y. Mardor and co-authors describe advances in drug delivery
Gastric Cancer - New gastric cancer study findings have been published by M. Jhawer and colleagues
Gastric Cancer - Reports from Yokohama City University add new data to research in gastric cancer
Glioblastoma - Reports outline glioblastoma study results from J.L. Clarke et al
Hepatocellular Cancer - Researchers' work from Beaujon University focuses on hepatocellular cancer
Incontinence - Recent findings in incontinence described by researchers from Mayo Clinic
Medullary Thyroid Cancer - Recent findings from University of Paris highlight research in medullary thyroid cancer
Non-Small Cell Lung Cancer - Recent findings in non-small cell lung cancer described by researchers from University of Texas
Osteosarcoma - New osteosarcoma research has been reported by scientists at Kyushu University
Ovarian Cancer - Research on ovarian cancer described by scientists at University of Bonn
Prostate Cancer - New prostate cancer research from G. Attard et al outlined
Prostate Cancer - Studies from C. Pezaro and co-authors have provided new information about prostate cancer
Squamous Cell Carcinoma - Reports outline squamous cell carcinoma study results from F.P. Worden et al
Angiogenesis - Scientists at College of Medicine, Department of Internal Medicine describe research in angiogenesis
Chronic Myeloid Leukemia Therapy - Studies from University of Heidelberg yield new information about chronic myeloid leukemia therapy
Colon Cancer Therapy - Research from Repatriation General Hospital, Department of Medical Oncology in the area of colon cancer therapy published
Follicular Lymphoma Therapy - Research from Memorial Sloan Kettering Cancer Center, Department of Medicine provides new data on follicular lymphoma therapy
Myeloma Therapy - New findings from St. Vincent's Comprehensive Cancer Center in the area of myeloma therapy published
Pharmacokinetics - Studies from Pfizer Inc. yield new data on pharmacokinetics
Affymax, Inc. - Affymax Provides Phase 3 Program Update for Investigational Drug, Hematide(TM), to Treat Anemia in Chronic Renal Failure
Antimicrobials - ISTA Pharmaceuticals Announces Preliminary Results of T-Pred Studies
Array BioPharma Inc. - Array BioPharma Announces Top-Line Results from Rheumatoid Arthritis Phase 2 Trial
Breast Cancer - Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program
Cempra Pharmaceuticals - Cempra Pharmaceuticals Initiates Phase 2/3 Clinical Study for an Oral Antibiotic to Treat Acute Bacterial Skin Structure Infections
Clinical Trial Research - Ascenta Therapeutics Receives Clearance to Initiate Clinical Trials With AT-406
Dyspareunia - QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena(TM) (Ospemifene Tablets) in Treatment of Postmenopausal Vaginal Atrophy
GlycoMimetics, Inc. - New Drug to Treat Sickle Cell Crisis Begins Pilot Study in Patients
Headache and Migraine - MAP Pharmaceuticals' Analysis of Positive Phase 3 LEVADEX(TM) Data To Be Presented in Late-Breaking Session at 14th Congress of the International Headache Society
Headache and Migraine - MultiVu Video Feed: POSITIVE PHASE 3 TRIAL DATA FOR INVESTIGATIONAL NEW MIGRAINE TREATMENT PRESENTED IN LATE-BREAKING SESSION AT 14th ANNUAL INTERNATIONAL HEADACHE SOCIETY CONGRESS
Hepatitis C Virus - Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
Human Genome Sciences, Inc. - Novel Evidence-Based Systemic Lupus Erythematosus SLE Responder Index Described in Peer Reviewed Publication as Potentially Significant Advance in Lupus Drug Development
Immunization - LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge
Influenza - Hovione's TwinCaps(R) Inhaler Delivers Successfully in Phase III Clinical Trials for Influenza
Inspire Pharmaceuticals, Inc. - Inspire Wins North Carolina Health & Life Sciences Award for Cystic Fibrosis Development Program
Knee Replacement - MoxDuo IR Demonstrates Fewer Side Effects than Percocet(R)
Medgenics, Inc. - Medgenics, Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference in New York
Merck and Co., Inc. - Merck Updates Status of Clinical Development Programs for Investigational CGRP Receptor Antagonist Treatments for Acute Migraine; MK-3207 Clinical Development Discontinued
NOXXON Pharma AG - NOXXON Is Awarded Research and Development Grant for First-in-Human Clinical Trial with Spiegelmer(R) NOX-A12
OSI Pharmaceuticals, Inc. - OSI Pharmaceuticals Initiates Phase III Registration-Oriented Study for OSI-906 in Adrenocortical Carcinoma and Phase I/II Study in Ovarian Cancer
Pharmaceuticals - Syntagon Technical Director to host presentation at CPhI Worldwide
Pluristem Therapeutics Inc. - Pluristem Begins Enrollment in U.S. With Unmatched Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease
Solid Cancer - Esperance Pharmaceuticals Announces Initiation of Clinical Studies of its Novel Membrane-disrupting Agent, EP-100, in Patients with Cancer
StemCells, Inc. - StemCells, Inc. to Initiate First Ever Neural Stem Cell Trial in Myelination Disorder
Targacept, Inc. - Data to be Presented on Multiple Targacept NNR Therapeutics at Society for Neuroscience Satellite Symposium
Type 1 Diabetes - Exsulin Corporation Announces Next Phase II Trial of Novel Islet Regeneration Treatment in Type 1 Diabetes
Weight Loss - VIVUS Announces Positive Results From Two Phase 3 Studies; Obese Patients on Qnexa Achieve Average Weight Loss up to 14.7% and Significant Improvements in Co-Morbidities
XenoPort, Inc. - XenoPort Reports Preliminary Results From a Safety and Tolerability Trial of Arbaclofen Placarbil in Patients With Acute Back Spasms
